2/17/23 17:11 | 2/16/23 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | M.d | 33 | 0.3300 | 0 | 100 | 3 | 3,335 | D | | | | | | | | | | | | | | |
2/17/23 17:11 | 2/16/23 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -108 | 1.08 | 0 | -100 | -3 | 3,335 | D | | | | | | | | | | | | | | |
1/19/23 16:12 | 1/17/23 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | M.d | 51 | 0.5100 | 0 | 100 | 3 | 3,373 | D | | | | | | | | | | | | | | |
1/19/23 16:12 | 1/17/23 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -128 | 1.28 | 0 | -100 | -3 | 3,373 | D | | | | | | | | | | | | | | |
12/20/22 16:07 | 12/16/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | M.d | 49 | 0.5100 | 0 | 96 | 5 | 1,898 | D | | | | | | | | | | | | | | |
12/20/22 16:07 | 12/16/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -137 | 1.43 | 0 | -96 | -5 | 1,898 | D | | | | | | | | | | | | | | |
10/14/22 16:15 | 10/14/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | M.d | 51 | 0.5100 | 0 | 100 | 6 | 1,898 | D | | | | | | | | | | | | | | |
10/14/22 16:15 | 10/14/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -166 | 1.66 | 0 | -100 | -5 | 1,898 | D | | | | | | | | | | | | | | |
7/15/22 16:03 | 7/14/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | M.d | 50 | 0.3300 | 0 | 150 | 9 | 1,898 | D | | | | | | | | | | | | | | |
7/15/22 16:03 | 7/14/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -408 | 2.72 | 0 | -150 | -7 | 1,898 | D | | | | | | | | | | | | | | |
5/13/22 16:02 | 5/13/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | M.d | 41 | 0.3300 | 0 | 125 | 7 | 1,898 | D | | | | | | | | | | | | | | |
5/13/22 16:02 | 5/13/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -240 | 1.92 | 0 | -125 | -6 | 1,898 | D | | | | | | | | | | | | | | |
3/18/22 16:03 | 3/16/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | M.d | 27 | 0.3300 | 0 | 82 | 5 | 1,898 | D | | | | | | | | | | | | | | |
3/18/22 16:03 | 3/16/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -217 | 2.65 | 0 | -82 | -4 | 1,898 | D | | | | | | | | | | | | | | |
2/16/22 16:03 | 2/14/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | M.d | 30 | 0.3300 | 0 | 90 | 5 | 1,898 | D | | | | | | | | | | | | | | |
2/16/22 16:03 | 2/14/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -337 | 3.74 | 0 | -90 | -5 | 1,898 | D | | | | | | | | | | | | | | |
12/17/21 21:23 | 12/16/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -600 | 5.22 | 0 | -115 | -7 | 1,551 | I | | | | | | | | | | | | | | |
11/18/21 16:07 | 11/16/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -925 | 8.04 | 0 | -115 | -6 | 1,666 | I | | | | | | | | | | | | | | |
11/3/21 19:38 | 11/1/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | M.d | 59 | 0.5100 | 0 | 115 | 7 | 1,781 | D | | | | | | | | | | | | | | |
11/3/21 19:38 | 11/1/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -1,632 | 14.15 | 0 | -115 | -6 | 1,781 | D | | | | | | | | | | | | | | |
10/15/21 16:02 | 10/15/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | M.d | 41 | 0.3300 | 0 | 125 | 8 | 1,781 | D | | | | | | | | | | | | | | |
10/15/21 16:02 | 10/15/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -1,225 | 9.80 | 0 | -125 | -7 | 1,781 | D | | | | | | | | | | | | | | |
9/17/21 16:01 | 9/15/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | M.d | 41 | 0.3300 | 0 | 125 | 8 | 1,781 | D | | | | | | | | | | | | | | |
9/17/21 16:01 | 9/15/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -940 | 7.52 | 0 | -125 | -7 | 1,781 | D | | | | | | | | | | | | | | |
6/9/21 19:22 | 6/7/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | M.dm | 10 | 0.3300 | 0 | 31 | 2 | 1,781 | D | | | | | | | | | | | | | | |
6/9/21 19:22 | 6/7/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.dm | -335 | 10.97 | 0 | -31 | -2 | 1,781 | D | | | | | | | | | | | | | | |
5/3/21 21:00 | 5/3/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | M.d | 100 | 0.5100 | 0 | 196 | 12 | 1,781 | D | | | | | | | | | | | | | | |
5/3/21 21:00 | 5/3/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -2,788 | 14.24 | 0 | -196 | -10 | 1,781 | D | | | | | | | | | | | | | | |
12/13/19 20:44 | 12/11/19 | OCGN | Ocugen, Inc. | DE | Health | Orthop | Orthopedic, Prosthetic & Surg | Musunuri Shankar | PA | DO | CEO | P.m | 158 | 0.3889 | 0 | 406 | 30 | 1,781 | D | | | | | | | | | | | | | | |